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In	 the	 United	 States,	 endemic	 mycoses—blastomycosis,	
coccidioidomycosis,	 and	 histoplasmosis—pose	 consid-
erable	 clinical	 and	 public	 health	 challenges.	Although	 the	
causative	 fungi	 typically	 exist	within	 broadly	 defined	 geo-
graphic	areas	or	ecologic	niches,	some	evidence	suggests	
that	cases	have	occurred	 in	humans	and	animals	not	ex-
posed	to	these	areas.	We	describe	cases	acquired	outside	
regions	of	 traditionally	defined	endemicity.	These	patients	
often	have	severe	disease,	but	diagnosis	may	be	delayed	
because	of	 a	 low	 index	 of	 suspicion	 for	mycotic	 disease,	
and	many	more	cases	probably	go	entirely	undetected.	In-
creased	awareness	of	these	diseases,	with	a	specific	focus	
on	their	potential	occurrence	in	unusual	areas,	 is	needed.	
Continued	interdisciplinary	efforts	to	reevaluate	and	better	
describe	areas	of	true	endemicity	are	warranted,	along	with	
a	more	nuanced	view	of	the	notion	of	endemicity.	The	term	
“nonendemic”	should	be	used	with	care;	mycoses	in	such	
regions	might	more	accurately	be	considered	“not	known	to	
be	endemic.”
Invasive fungal diseases are a growing public health problem. The endemic mycoses found in North America, 
namely, blastomycosis, coccidioidomycosis, and histoplas-
mosis, are caused by thermally dimorphic fungi and can 
infect immunocompetent or immunocompromised hosts, 
often resulting in severe illness and death (1). Infection 
is typically acquired via inhalation of fungal spores and 
usually results in a respiratory illness, although the clini-
cal spectrum can range from asymptomatic to life-threat-
ening disseminated disease (1–4). Most infections with 
Blastomyces, Coccidioides, and Histoplasma spp. occur 
sporadically in areas to which these fungi are geographi-
cally restricted, also referred to as mycosis-endemic areas 
(1). Cases outside these regions often result from travel, 
infection reactivation, latent infection in immunosup-
pressed hosts, or (less commonly) exposure to fomites from 
mycosis-endemic areas (1,3). However, a growing body of 
evidence suggests that some cases occur in patients with 
no known exposures to areas in which these diseases are 
most common. Because prevention of these infections is 
challenging, increased awareness that they can be acquired 
in unusual geographic locations is needed to promote early 
diagnosis and treatment.
Search Strategy and Selection Criteria
To identify infections outside the known mycosis-endem-
ic areas in the United States, we searched PubMed and 
Google Scholar without date or language restrictions by 
using combinations of the following terms: “non-endem-
ic,” “outside endemic area,” “blastomycosis,” “histoplas-
mosis,” “coccidioidomycosis,” and “fungal infection.” We 
included publications in which the authors describe infec-
tions believed to be acquired from the local environment 
outside the traditionally defined mycosis-endemic areas in 
the United States. We excluded cases consistent with fomi-
te transmission. We also reviewed relevant references in 
selected articles.
Blastomycosis
Blastomycosis is considered endemic to the south-central, 
southeastern, and midwestern US states, particularly those 
bordering the Ohio and Mississippi Rivers and in parts of 
the United States and Canada surrounding the Great Lakes 
and the Saint Lawrence River (2,5). Hyperendemic foci ex-
ist in north-central Wisconsin and western Ontario. Areas 
of blastomycosis endemicity are based primarily on reports 
of symptomatic disease and was first described in the late 
1930s (5). Although the epidemiology of blastomycosis is 
not as well understood as that of the other mycoses endemic 
to North America, the incidence seems to be increasing in 
some states, including Illinois, Indiana, and Wisconsin (2).
Cases of canine blastomycosis are often recognized 
as sentinels for human disease, presumably because dogs’ 
outdoor exposures are similar to, but potentially more ex-
tensive than, those of their human counterparts (6). A study 
in Illinois estimated blastomycosis incidence among dogs 
to be >8 times that among humans, and during 2001–2007, 
the annual incidence among dogs increased 50-fold (7). In 
addition to these apparent increases, blastomycosis has also 
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been documented far outside the known disease-endemic 
areas. One report describes 2 cases probably acquired in 
the Pacific Northwest: 1 case of ocular blastomycosis in a 
golden retriever that had never left Washington state and 1 
case of disseminated disease in a Rottweiler mix with no 
history of travel outside of British Columbia (Table 1) (8).
Similarly, several cases of blastomycosis in humans 
have also occurred far outside the traditionally defined dis-
ease-endemic area. A report from 1951 describes dissemi-
nated blastomycosis in an agricultural worker in Oregon (9). 
More recently, an immunosuppressed 6-year-old girl was 
thought to have contracted primary cutaneous blastomy-
cosis in north-central Florida (10). Two unrelated cases of 
osseous blastomycosis of the knee without apparent pulmo-
nary involvement were probably acquired in Nebraska (11): 
the first case was in a previously healthy man from western 
Nebraska who sustained a knee injury involving farm equip-
ment ≈1 year before diagnosis, and the second case was in a 
man from central Nebraska with a 1-month history of knee 
pain but no acute knee injury (11). These cases highlight 
the difficulties associated with diagnosing blastomycosis 
in patients with no exposures to disease-endemic areas and 
whose disease manifestations are unusual (11). Similarly, 2 
other cases in previously healthy adults occurred in Colo-
rado (12); each patient had pulmonary disease and had been 
extensively exposed to soil while excavating prairie dog 
burrows on the eastern slope of the Rocky Mountains (12). 
De Groote et al. suggest that higher-than-normal rainfall in 
that region could have contributed to conditions favorable 
for Blastomyces growth and sporulation (12).
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Table 1.	Cases	of	blastomycosis,	coccidioidomycosis,	and	histoplasmosis	acquired	outside	the	traditionally	defined	mycosis-endemic	
areas,	United	States* 
Infection	and	
reference 
No.	cases,	
species Location Type	of	infection Method	of	diagnosis 
Blastomycosis     
  (8) 1,	dog Central	Washington Ocular Histopathology	and	culture 
  (9) 1,	human Oregon NS Culture 
  (10) 1,	human North-central	Florida Primary	cutaneous Histopathology 
  (11) 2,	human Western	(1	case)	and	central	
Nebraska	(1	case) 
Bone Culture	plus	confirmation	by	DNA	
probe 
  (12) 2,	human Central	Colorado Pulmonary Histopathology	and	culture	(1	case),	
histopathology	and	culture	plus	
confirmation	by	DNA	probe	(1	case) 
Coccidioidomycosis     
  (13) 61,	human Butte	County,	California Pulmonary,	complications	
NS 
Clinical	findings	(61	cases),	skin	test	
or	serology	(27	cases) 
  (14) 17,	human Tehama	County,	California Pulmonary,	complications	
NS 
Clinical	findings	(17	cases),	skin	test	
or	serology	(10	cases) 
  (15) 10,	human Northeastern	Utah Pulmonary,	complications	
NS 
Clinical	findings	(10	cases),	
serology	(9	cases) 
  (16) 3,	human South-central	Washington 1	pulmonary,	1	primary	
cutaneous,	1	pulmonary	 
meningitis 
Culture	and	serology 
Histoplasmosis     
  (8) 1,	dog Western	Idaho Disseminated Histopathology	and	PCR 
  (17) 1,	otter Kodiak	Island,	Alaska Disseminated Histopathology	and	PCR 
  (18) 5,	cats California	(2	cases),	Colorado	
(2	cases),	and	New	Mexico	(1	
case) 
Disseminated	(4	cases),	
localized	(1	case) 
Histopathology	and	PCR	(4	cases),	
culture	and	PCR	(1	cases) 
  (19) 2,	cats San	Joaquin	Valley,	California Pulmonary	(1	case),	
cutaneous/ocular	(1	case) 
Cytopathology	(1	case),	
cytopathology	and	culture	plus 
confirmation	by	DNA	probe	(1	case) 
  (20) 2,	
raccoons 
San	Francisco,	California Disseminated Histopathology,	culture,	and	PCR 
  (21) 2,	human California NS Skin	test	and	chest	x-ray 
  (22) 1,	human California Endocarditis Histopathology,	PCR,	and	urine EIA 
  (23) 1,	human Arizona Gastrointestinal	 central	
nervous	system 
Histopathology	and	culture 
  (24) 6,	human Southwestern	(3	cases)	and	
eastern	(2	cases)	Montana;	
southwestern	Idaho	(1	case) 
Disseminated	(3	cases),	
pulmonary	(1	case),	
unknown	(2	cases) 
Histopathology	(2	cases),	culture	(2	
cases),	urine	EIA	(2	cases) 
  (25) 5,	human Southern	Florida Disseminated Histopathology 
  (26) 1,	human Northern	Florida Pulmonary Skin	test	and	serology 
  (27) 15,	human Central	New	York  Histopathology	(10	cases),	serology	
(9	cases) 
  (28) 1,	human Staten	Island,	New	York Pulmonary Skin	test	and	serology 
  (29) 5,	human South	Bronx,	New	York Disseminated Culture 
*EIA, enzyme	immunoassay;	NS,	not	specified. 
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Moisture is believed to be an influential factor in the 
growth and dispersal of Blastomyces, although the precise 
ecology of the organism is not well understood, partly be-
cause of the difficulties associated with its recovery from 
the environment (2). Previously, blastomycosis was be-
lieved to be caused by 1 species, B. dermatitidis, but phylo-
genetic analysis indicates that B. dermatitidis is probably 2 
species, B. dermatitidis and B. gilchristii (30). Furthermore, 
B. gilchristii is hypothesized to inhabit a specific ecologic 
niche in areas of hyperendemicity, whereas B. dermatitidis 
may be adapted to a wider range of environmental condi-
tions and distribution throughout North America may be 
scattered (30). Additional research into the genetic, geo-
graphic, and clinical differences between these 2 species 
may contribute to a better understanding of blastomycosis 
epidemiology, both inside and outside the traditionally de-
fined areas of endemicity.
Coccidioidomycosis
Coccidioidomycosis is caused by Coccidioides spp. and 
is endemic to the southwestern United States and parts 
of Mexico and Central and South America. An estimated 
60% of Coccidioides infections are asymptomatic (3,31). 
The remaining 40% of infections most commonly cause an 
influenza-like illness also known as Valley fever, which is 
often self-limiting but can result in serious illness, particu-
larly because some cases progress to severe pulmonary or 
disseminated disease. Prior Coccidioides infection usually 
provides immunity against reinfection, which can be as-
sessed by use of a skin test antigen.
The first complete description of the geographic dis-
tribution of coccidioidomycosis was accomplished through 
large-scale evaluations of coccidioidin sensitivity prevalence. 
During the mid-1940s to early 1950s, coccidioidin skin tests 
were performed on ≈110,000 lifetime residents of a single 
county, most of whom were white men and women 17–21 
years of age (32). The study identified Arizona, California, 
Nevada, New Mexico, Utah, and Texas as Coccicioides-en-
demic states; the highest rates of skin test positivity (50%–
70%) were in California’s southern San Joaquin Valley and 
Arizona’s Sonoran Desert (32). Point-source coccidioidomy-
cosis outbreaks near the borders of the areas identified by 
Edwards and Palmer further contributed to what is known 
about the geographic distribution of Coccidioides spp. (32). 
For example, in an outbreak that occurred in 1970, at least 
61 archeology students were affected after excavating Native 
American ruins near Chico, Butte County, California, ≈70 
miles north of the recognized disease-endemic area at the 
time (13). In 1972, at least 17 persons were infected during 
a similar excavation near Red Bluff, Tehama County, Cali-
fornia, 20 miles north of the previous outbreak near Chico 
(14). In 2001, another outbreak occurred among 10 workers 
at an archeological site in Dinosaur National Monument in 
northeastern Utah, ≈200 miles north of the previously de-
fined disease-endemic area (15). These outbreaks support the 
idea that foci of Coccidioides exist outside of the traditional 
areas of endemicity, yet they are not always represented on 
maps depicting these areas.
During 2010–2011, three unrelated coccidioidomyco-
sis cases were identified in south-central Washington, far 
north of the area of known Coccidioides endemicity (16). 
Whole-genome sequencing of 1 clinical isolate from the 
patient and soil isolates recovered from the patient’s loca-
tion of exposure revealed that the isolates were identical, 
providing direct evidence that the infection was acquired in 
Washington (33).
Evidence of coccidioidomycosis far outside the areas 
of known endemicity has also been seen in fossil records. 
Coccidioides spherules were morphologically identified 
in 2 fossilized, 8,500-year-old bison mandibles recovered 
from a flood plain in central Nebraska, suggesting that bi-
son had migrated from disease-endemic areas or that Coc-
cidioides previously inhabited a different or broader geo-
graphic range (34).
Histoplasmosis
Histoplasmosis-endemic areas were also established by us-
ing nationwide skin testing to evaluate histoplasmin sensi-
tivity among ≈70,000 white persons, 17–21 years of age, 
who were lifetime residents of a single county (35). The 
highest proportion of positive reactors (60%–90%) oc-
curred in states bordering the Ohio and Mississippi River 
valleys; a zone of moderate prevalence (30%–60%) extend-
ed outward around the central area for up to 300 miles (35). 
Histoplasma spp. seems to be less geographically restricted 
than Blastomyces or Coccidioides and is also endemic to 
parts of central America and various other locations world-
wide, such as Africa and Asia. Because Histoplasma grows 
well in soil containing bird or bat droppings, the organism 
probably exists in microfoci outside of these broadly de-
fined regions (4).
Histoplasma can infect many animal species and has 
been found in domestic and wild animals far outside the 
traditional disease-endemic areas, including disseminated 
disease in a dog with no history of travel outside of west-
ern Idaho (8) and in a northern sea otter found in Alaska 
(17). Otters do not migrate, so the authors of that report 
hypothesized that the infection was acquired from wind-
borne spores or spores carried on the wings, feet, or beaks 
of migratory birds (17). Spores carried in seawater may be 
another possible explanation (36).
Histoplasmosis has also occurred in cats in the puta-
tively non–disease-endemic states of Colorado, New Mex-
ico, and California (18,19). Multilocus sequence typing of 
cat tissue samples indicated that the infecting strains of H. 
capsulatum were closely related to but clustered separately 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	21,	No.	11,	November	2015	 1937
SYNOPSIS
from the North American-1 clade (1 of 2 clades common 
to North America), suggesting that the genetic differences 
represent either geographic variation among H. capsulatum 
or differences in the strains capable of infecting animals 
and humans (18). Histoplasmosis in other cats near Va-
caville, California (G. Thompson, unpub. data), and in two 
6-month-old raccoons rescued near San Francisco (20) pro-
vides further evidence that Histoplasma may be established 
in California.
Among humans, histoplasmosis potentially acquired in 
California was first described in 1949; in a series of 5 cases 
of histoplasmosis in children in California, 1 patient was a 
girl who had never traveled >100 miles from San Francisco 
and another was a girl who had lived only in California and 
Wyoming, which is also not a traditional histoplasmosis-
endemic area (21). Notably, these histoplasmosis diagno-
ses were based on chest radiograph findings and positive 
results for histoplasmin skin tests, which can cross-react 
with Coccidioides. A more recent case occurred in the Cen-
tral Valley of California, in an immunocompetent 87-year-
old man who seroconverted during a febrile illness and 
in whom Histoplasma endocarditis later developed (22). 
Another case provides further evidence of histoplasmo-
sis far west of the traditional disease-endemic area; in an 
immunocompetent woman from Arizona with no history 
of travel to histoplasmosis-endemic areas, an initial gas-
trointestinal infection was later followed by development 
of an intramedullary spinal cord abscess (23). Another 6 
unrelated cases were reported from Montana (5 cases) and 
Idaho (1 case); of these 6 patients, 5 had immunocompro-
mising conditions and 3 experienced substantial diagnostic 
delays, probably because of the low index of suspicion for 
histoplasmosis in an unusual location (24).
Histoplasmosis has also been observed both south and 
north of the known disease-endemic areas. In a series of 7 
cases of disseminated histoplasmosis in HIV/AIDS patients 
from south Florida, 5 patients had no relevant travel history 
(25). In northern Florida, acute pulmonary histoplasmosis 
developed in a college student after he had explored a bat-
infested cave (26). New York is repeatedly described as 
a non–histoplasmosis-endemic area and is typically not 
represented on maps depicting histoplasmosis-endemic ar-
eas, probably because the skin test surveys by Manos et al. 
estimated <10% positive reactors for the entire state and 
<2% positive reactors in certain counties (35). However, 
cases reported from New York date back several decades, 
including an outbreak beginning in 1978 at a prison in ru-
ral central New York; this outbreak was suspected to have 
been related to removal of accumulations of bird droppings 
and trees that served as bird roosting sites (27). Evidence 
also exists of histoplasmosis acquisition in urban areas 
of New York, such as in a previously healthy child from 
Staten Island with extensive exposure to birds (28) and in 
a series of 5 cases of disseminated histoplasmosis in HIV/
AIDS patients from the south Bronx who had no exposures 
to birds or bats (29).
Discussion
Reasons for the observed occurrences of blastomycosis, 
coccidioidomycosis, and histoplasmosis outside areas to 
which they are traditionally classified as endemic are un-
clear but are probably multifaceted. Because weather and 
climate affect the growth and distribution of these fungi in 
these regions, these factors might also contribute to envi-
ronmental conditions that could support these fungi else-
where. The role of animal vectors in the life cycles and 
geographic distribution of these fungi is unknown; rodents 
have been suggested as possible reservoirs for Coccidi-
oides, and birds and bats can carry Histoplasma, indicat-
ing that they may be capable of introducing microfoci in 
geographic regions not considered to be endemic (37). In 
contrast, areas in which endemicity seems to be emerging 
might represent areas of previously unrecognized disease. 
Despite potential increased clinician awareness, these dis-
eases probably remain underdiagnosed. Documented cases 
also probably represent the most severe or symptomatic 
cases, although most cases are unrecognized, and self-reso-
lution is the norm. Fungal infections outside the traditional 
mycosis-endemic areas clearly represent an emerging pub-
lic health issue; however, the full scope of the problem re-
mains largely unknown.
Maps of the mycosis-endemic areas are based on out-
dated and incomplete data and are often reprinted without 
substantial revisions, even as new data regarding suspected 
endemicity become available. Although sufficient evidence 
exists that the original descriptions of these diseases’ dis-
tributions are probably not entirely representative of their 
true range, no comprehensive attempts have been made to 
systematically reevaluate these estimates. Several potential 
strategies exist to clarify the true areas of endemicity for 
these diseases (Table 2). 
First, the distributions of histoplasmosis and coccidi-
oidomycosis were historically defined by large-scale skin 
test surveys, and it is reasonable to assume that a similar 
method could be used to further refine our understanding 
of these areas. Skin test reagents to detect prior exposure to 
Histoplasma and Coccidioides have been unavailable in the 
United States for more than a decade, but a reformulated 
spherule-derived skin test antigen (Spherusol; AllerMed, 
San Diego, CA, USA) to detect delayed-type hypersensi-
tivity to Coccidioides was recently approved by the Food 
and Drug Administration. Although access to skin testing 
may enable reduction of potential exposure for nonimmune 
patients, widespread skin test surveys to reevaluate areas of 
endemicity may be difficult to implement because of cost 
and concerns about reagent specificities.
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Second, improved disease surveillance and manda-
tory case reporting could improve detection of infections 
in persons not exposed to areas of known endemicity and 
would contribute to a more comprehensive epidemiologic 
understanding of these infections in general. One of the 
current challenges with state-based reporting methods is 
that these diseases are typically reportable only in states 
within the traditionally defined areas of endemicity (and 
are sometimes not reportable even in states with known en-
demicity); thus, infections acquired in unusual geographic 
locations probably go undocumented. In addition, identi-
fying the location of exposure for persons with histories 
of travel to places where these diseases are most common 
may be difficult. Because exposures of animals are theo-
retically similar to those of humans but animals travel less, 
animals can be good sentinels for human disease; however, 
no comprehensive surveillance methods exist to monitor 
fungal diseases in animals. Epidemiologic surveillance for 
blastomycosis, coccidioidomycosis, and histoplasmosis in 
humans and animals fundamentally relies on accurate di-
agnosis. The challenges associated with diagnosing these 
infections are well recognized; sensitivity of histopathol-
ogy and cytology is low, and cross-reactions between the 
endemic mycoses are a particular concern with serologic 
testing (2–4). Our review is subject to the same limitations 
as those of the original reports regarding diagnostic meth-
ods for non–culture-confirmed cases.
Third, because detection of pathogenic fungi in envi-
ronmental samples is a more direct measure of whether a 
given location can support the fungus than are data about 
the occurrence of disease, environmental studies could be 
helpful for further characterizing the areas of endemic-
ity. Testing of environmental samples for Coccidioides, 
Histoplasma, or Blastomyces has traditionally relied on 
culture methods and animal inoculation, which are associ-
ated with low sensitivity and which are labor and resource 
intensive; however, molecular methods such as PCR are 
promising (33). As these technologies advance and be-
come more widely used, they may serve as valuable tools 
to help determine sources of infection in environmental 
material and air. 
Last, ecologic niche modeling has been beneficial for 
understanding the probable distribution and environmental 
conditions favorable for Blastomyces (38) and Coccidioi-
des (39). Better environmental detection methods could 
help refine the inputs for these types of models, thereby 
improving their predictive abilities.
The concept of endemicity of fungal diseases is well 
established and has proven useful, but it may, in some in-
stances, be potentially misleading. An “endemic disease” 
is one “occurring frequently in a particular region or popu-
lation” (40). The dichotomy of endemic and nonendemic 
diseases or endemicity or nonendemicitiy in geographic 
areas may not be fully adequate to capture the nuances 
of fungal disease epidemiology; the seemingly increasing 
frequency of acquisition of fungal infections in areas well 
removed from those known to be endemic suggests that 
consideration should be given to discarding the term “non-
endemic” in favor of “not known to be endemic” (Figure). 
Furthermore, even within a region of known endemicity, 
there may be areas in which the pathogen seems to be ab-
sent, as reflected in a lack of recognition of locally acquired 
infections. In contrast, some areas within a region of en-
demicity may be regions of hyperendemicity, contributing 
large numbers of cases, and others may be regions of hy-
poendemicity. These conceptual issues pertain not only to 
space, but also to time; hyperendemicity in some areas may 
be seasonal or endemicity only transient. Approaching the 
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Table 2. Advantages	and	disadvantages	of	potential	strategies	to	refine	areas	of	blastomycosis,	coccidioidomycosis,	and	
histoplasmosis	endemicity 
Strategy Advantages Disadvantages 
Skin	testing Could	cover	large	geographic	areas; is	likely	to	yield	
results	that	could	be	easily	compared	with	early	
studies	of	skin	test	reactivity	distribution 
Availability,	specificity,	and	cost	of	reagents	may	be	
limiting; may	be	difficult	to	identify	persons	who	have	
no	relevant	travel	history 
Expand	surveillance	for	
fungal	diseases	in	
humans 
Provides	foundation	for	more	comprehensive	
surveillance	already	in	place	in	some	states;	would	
provide	valuable	information	about	the	overall	
epidemiology	of	these	diseases 
Disease	reporting	can	be	time- and	resource-
intensive	for	state	and	local	health	departments;	
yield	for	areas	of	low	or	no	endemicity	is	potentially	
low; not	likely	to	capture	information	on	
asymptomatic	infections; may	be	difficult	to	pinpoint 
location	of	exposure	or	rule	out	reactivation	disease	
in	persons	who	have	extensive	travel	histories 
Surveillance	for	fungal	
diseases	in	animals 
Animals	can	be	good	sentinels	for	human	disease	
because	of	potentially	more	extensive	
environmental	exposures	and	limited	travel 
No	comprehensive	surveillance	systems	are	
currently	in	place;	would	be	time	and	resource	
intensive	to	establish 
Improved	environmental	
detection 
Detection	of	fungi	in	the	environment	can	be	a	more	
direct	measure	of	endemicity than	disease	data; 
positive	results	can	provide	a	more	definitive	link	
between	infection	and	the	environment 
Culture-based	methods	are	insensitive;	new	
technologies	still	in	development; is	challenging	for	
large	geographic	areas 
Additional	ecologic	niche 
modeling 
Leads	to	increased	understanding	of	the	
fundamental	niche	for	these	fungi	and	locations	
where	human	or	animal	exposures	could	occur 
Model	validity	relies	on	the	quality	of	reported	
locations	of	human	and	animal	diseases,	
environmental	sampling	results,	or	both 
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notion of endemicity for fungal diseases with a more nu-
anced and dynamic view has both epidemiologic and clini-
cal value. Future work defining fungal disease endemicity 
should use a classification such as this.
Because primary prevention of these infections is 
extremely difficult, early diagnosis and treatment are 
particularly beneficial and may contribute to improved 
outcomes. The nonspecific symptoms of blastomycosis, 
coccidioidomycosis, and histoplasmosis are often clini-
cally indistinguishable from those of other community-
acquired respiratory illnesses. Mild or self-resolving 
cases frequently go undetected, and diagnoses may be 
missed or delayed, especially in settings where these dis-
eases are uncommon. As a result, diagnoses in unexpected 
geographic locations probably represent the most severe 
cases. Therefore, clinicians should not exclude the pos-
sibility of these infections in patients who have not been 
exposed to known areas of endemicity. 
The clinical and public health challenges associated 
with these diseases are not limited to the United States; the 
distribution of Blastomyces and Histoplasma extends into 
Canada, and histoplasmosis and coccidioidomycosis com-
prise a substantial burden of disease in parts of Central and 
South America. Further ecologic and epidemiologic stud-
ies, including revision of the geographic distribution, are 
needed to provide a better understanding the public health 
implications of these fungal diseases in the United States 
and elsewhere around the world.
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